Remove topic nih
article thumbnail

GreenLight and US NIH partner to develop Covid-19 vaccine for variants

Pharmaceutical Technology

GreenLight Biosciences has entered a partnership with the US National Institutes of Health (NIH) for the development of Covid-19 vaccines, which offer broader protection against new variants and with durable effects. Topic sponsors are not involved in the creation of editorial content.

article thumbnail

Forge Biologics joins BGTC for new AAV gene therapies development

Pharmaceutical Technology

The AMP programme is a public-private partnership between a number of biopharmaceutical and life sciences companies, the US Food and Drug Administration (FDA) and the National Institutes of Health (NIH), along with non-profit and other organisations. Topic sponsors are not involved in the creation of editorial content.

96
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Department of Defense Congressionally Directed Medical Research Programs

Putting Patients First Blog

In 1983, the Department of Health and Human Services (HHS) established the Public Health Service Task Force on Women’s Health Issues, which was followed by the National Institutes of Health’s (NIH) Office of Research on Women’s Health (ORWH), again created in response to a lack of female inclusion in clinical studies.

52
article thumbnail

Robotic capsule could replace injected biologics

European Pharmaceutical Review

Inflammatory conditions such as ulcerative colitis have could be treated with topical medications using this innovative approach by maximising local concentration of the drug in the tissue. The research was partly funded by the National Institutes of Health (NIH) and MIT’s Department of Mechanical Engineering.

137
137
article thumbnail

Amplo Biotechnology receives NIH-NIAMS grant for gene therapy AMP-201

Pharmaceutical Technology

Amplo Biotechnology has received a fast track phase I/II STTR grant from the NIH-NIAMS [National Institutes of Health’s National Institute of Arthritis and Musculoskeletal and Skin Diseases] for its gene therapy AMP-201. Topic sponsors are not involved in the creation of editorial content.

97
article thumbnail

Samsung Biologics, GreenLight conclude Covid-19 vaccine engineering run

Pharmaceutical Technology

The latest development comes after GreenLight signed a partnership with the US National Institutes of Health (NIH) to develop Covid-19 vaccines against new variants. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Vaccines 104
article thumbnail

FDA AdComm Agenda Covers the Bases

Eye on FDA

And now, three agencies that have seen an erosion in public confidence – FDA, CDC and NIH, will participate in an FDA Advisory Committee meeting that will discuss vaccine development. The agenda has been posted for the October 22 meeting, and the discussion will be available to view on YouTube, according to FDA Commissioner Hahn.